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Abstract
Background Helicobacter infection is the main risk fac-
tor in developing gastric cancer. Mesenchymal stem cells
(MSCs) are non-hematopoietic stromal cells, which are
able to differentiate into different cell lineages. MSC
contribute to cancer development by forming the tumor
directly, contributing to the microenvironment, or by pro-
moting angiogenesis and metastasis. CXCR4/SDF-1 axis is
used by MSC in trafficking, homing, and engraftment at
chronic inflammation sites, and plays an important role in
tumorigenesis.
Aim To determine if CXCR4 receptor has a role in MSC
contribution to the development of Helicobacter-mediated
gastric cancer.
Methods SDF-1 and CXCR4 expression in mouse gastric
mucosa in the setting of acute and chronic inflammation was
measured using RT-PCR. Mouse culture-adapted MSC
express CXCR4. Wild-type C57BL/6 mice infected with
Helicobacter felis for 6 months or controls were given IV
injections of CXCR4 knock-down MSC. Animals were fol-
lowed for another 4 months. Homing of MSC in the stomach
was quantified using RT-PCR. MSC differentiation into
gastric epithelia lineages was analyzed using immunohisto-
chemistry and fluorescent in situ hybridization.
Results CXCR4 and SDF-1 are both upregulated in the
settings of Helicobacter-induced chronic gastric inflam-
mation. CXCR4 is fully required for homing of MSC to the
stomach in acute gastric inflammation, but only partially in
Helicobacter-induced gastric cancer. MSC lead to gastric
intraepithelial neoplasia as early as 10 months of Helico-
bacter infection.
Conclusions Our results show that MSC have a tumori-
genic effect by promoting an accelerated form of gastric
cancer in mice. The engraftment of MSC in chronic
inflammation is only partially CXCR4-dependent.
Keywords Gastric cancer  Helicobacter  Mesenchymal
stem cells  CXCR4  SDF-1
Introduction
Gastric cancer is the second most common cause of cancer-
related death, and the 4th most common form of cancer in
the world. Over 900,000 new cases of gastric cancer are
diagnosed annually and approximately 700,000 patients die
from it each year worldwide [1, 2]. Helicobacter pylori, a
class I carcinogen, is the most common risk factor of
gastric cancer and one of the most common infections in
the world [2]. All Helicobacter-infected patients develop
gastric inflammation with or without clinical symptoms,
C. Stoicov  H. Li  J. H. Liu  J. Houghton (&)
Division of Gastroenterology, Department of Medicine,
University of Massachusetts Medical School, 364 Plantation
Street, Worcester, MA 01635, USA
e-mail: jeanmarie.houghton@umassmed.edu
C. Stoicov
e-mail: calin.stoicov@umassmed.edu
H. Li
e-mail: hanchen.li@umassmed.edu
J. H. Liu
e-mail: jian.liu@umassmed.edu
C. Stoicov  H. Li  J. H. Liu  J. Houghton
Department of Cancer Biology, University of Massachusetts
Medical School, 364 Plantation Street, Worcester,
MA 01635, USA
123
Dig Dis Sci (2013) 58:2466–2477
DOI 10.1007/s10620-013-2782-y
but fortunately less than 1 % of patients will go on to
develop gastric cancer. Two-thirds of gastric cancer
patients have locally advanced or metastatic disease when
diagnosed, making the currently available treatments
ineffective [3].
Helicobacter felis-induced chronic inflammation is
required for a major contribution to the development of
gastric cancer [2, 4]. The immune response of the host, in
combination with host genetics, environmental factors,
diet, and concomitant infections with other pathogens
promote Helicobacter-induced gastric cancer [5].
Chronic inflammation has been long recognized as a risk
factor in cancer, as many types of malignancies are initi-
ated in the settings of repetitive inflammatory injuries
[6, 7].
There are two proposed models in the development of
cancer: stochastic and hierarchical models. The stochastic
model states that cancer is a clonal expansion of tumori-
genic cells that have accumulated mutations. The hierar-
chical model proposes that cancer evolves from a single
tumor-initiating (stem) cell. The concept of a tumor-initi-
ating cell (TIC) is novel and is based on the fact that not all
cancer cells have an equal oncogenic potential ex vivo in
animal models. The TIC is reminiscent of a stem cell based
on the fact that it has self-renewal and transdifferentiation
capabilities into a non-TIC [8]. The environment sur-
rounding the TIC and subsequently the cancer cells is of
paramount importance. The tumor microenvironment is
made up of endothelial cells, carcinoma-associated fibro-
blasts (CAF), adipocytes, mesenchymal stem cells (MSCs)
(including bone marrow-derived), and tumor-associated
macrophages. Bone marrow-derived mesenchymal stem
cells (BMD-MSC) can differentiate in vivo and in vitro
into other cellular components of the tumor-supporting
cells [9–11].
Bone marrow-derived cells (mesenchymal and hemato-
poietic stem cells) rely on the CXCR4/SDF-1 axis for
trafficking, homing, and engraftment. The stromal-derived
factor-1 (SDF-1, also known as CXCL12) is a 68-amino
acid chemokine with a broad range of functions including
lymphocyte and mononuclear cells trafficking to inflam-
matory sites, embryonic development, bone marrow stem
cell homeostasis, and angiogenesis [12, 13].
CXCR4, is a 352-amino acid seven-span transmembrane
G-protein coupled receptor and one of the receptors that
binds SDF-1. Upon SDF-1 binding to CXCR4 receptor, the
Ga unit of the G-protein will exchange the GDP molecule
with GTP, resulting in the activation of phospholipase C
(PLC), protein kinase C (PKC), and activation of phos-
phatidylinositol 3-kinase (PI3K). Ga will simultaneously
inhibit the adenylate cyclase function, therefore resulting in
a reduction of cyclic AMP (cAMP) levels [14]. These
events will lead to cell migration, proliferation, and cyto-
skeletal/actin modifications. CXCR7 is a second possible
receptor for SDF-1; however, it appears that it requires
CXCR4 cooperation for SDF1 binding [15]. It has been
shown that CXCR7 promotes transedothelial migration,
adhesion, and survival of renal progenitor cells [16],
functions that are similar to those of CXCR4.
Secreted trefoil factor 2 (TFF2) is a known marker of
spasmolytic peptide positive gastric cell lineages and is
expressed in gastric mucous neck cells. It was recently
demonstrated that TFF2 activated CXCR4, thus inducing
immunologic and tumorigenic responses in vivo [17].
The CXCR4/SDF-1 axis plays an important role in
normal physiology and in cancer biology. The CXCR4
receptor was shown to be over-expressed in multiple
types of primary cancer [18], including gastric cancer
[19] and its expression is correlated with the develop-
ment of peritoneal carcinomatosis. It is theorized that
peritoneal mesothelial cells over-secrete SDF-1 and may
attract metastatic gastric cancer cells from a primary
tumor [20]. The CXCR4/SDF-1 signaling axis is also
known to promote angiogenesis, local and distal metas-
tasis, and cell survival [21]. Both CXCR4 and SDF-1
have been shown to be upregulated in the setting of
Helicobacter-induced inflammation and gastric cancer
[22, 23]. Expression of CXCR4 and SDF-1 is higher in
gastric cancer with lymph node metastasis when com-
pared to non-metastatic gastric cancer and normal gastric
tissue; gastric cancer cell lines express CXCR4 and have
a potent proliferation and migratory response to SDF-1
stimulation in vitro [24].
In the mouse model of Helicobacter infection, BMDC
are the source of metaplasia and intraepithelial neoplasia in
both the H. felis [22] and H. pylori [25] models, supporting
a role for BM-MSC as the TIC for gastric cancer. Pre-
sumably, recruited cells undergo mutations due to chronic
inflammation of the stomach, thus initiating cancer. Also,
we have previously shown that BMD-MSC can undergo
mutations at an accelerated rate in culture and, when
infused into an ‘‘at risk’’ mouse, greatly accelerates cancer
progression [26]. Combined, these findings suggest that
MSC contribute to cancer by both direct and indirect
mechanisms, which may depend upon when and where the
oncogenic mutations occur.
We hypothesized that the CXCR4 receptor might play a
key role in MSC contribution to the development of gastric
cancer by recruiting and/or retaining cells in the inflamed
mucosa. Therefore, using a combination of approaches, we
evaluated whether CXCR4 is required for MSC trafficking
to the Helicobacter-induced gastric inflammation, and
whether this process promotes a more advanced form of
gastric cancer.
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Materials and Methods
Animals
The University of Massachusetts Institutional Animal Care
and Use Committee approved all animal work. Six- to
eight-week-old male C57BL/6 mice which were viral
antibody (Ab)-free, parasite-free, and bacterial pathogen-
free, inclusive of Helicobacter species, were purchased
from Jackson Laboratories (Bar Harbor, ME, USA) and
housed in microisolator cages, fed standard chow, and
allowed free access to water.
Helicobacter Infection
Helicobacter felis (strain 49179 from the American Type
Culture Collection, Manassas, VA, USA) was grown on
Trypticase soy agar with 5 % sheep blood under micro-
aerophilic conditions at 37 for 4 days. Bacteria were
harvested and 1 9 107 CFU (colony-forming units) were
resuspended in 500 ll total volume of Trypticase soy. Mice
were restrained by hand and gavaged with H. felis via a
20-gauge feeding tube (Popper and Sons, New Hyde Park,
NY, USA) three times at 2-day intervals.
Alcohol-induced Acute Gastric Injury
Mice were gavaged with a dose of 200 ll of 50 % ethanol
(5 g of alcohol/kg of mouse weight) in normal saline (NaCl
0.9 %, pH 7.2) [27]. Each mouse was given one dose a day
for four successive days, then sacrificed at day 5. Each
mouse weighed 30 g.
Culture and Characterization of Culture Adapted
Mesenchymal Stem Cells (MSCs)
Total marrow harvesting and MSC characterization was
done as previously described [22, 26].
Mesenchymal Stem Cells Injection in Mice
One million RFP-labeled MSC (shScramble or shCXCR4)
were strained through a 40-lm strainer and suspended in
500 ll of PBS. Cells were intravenously injected via tail
vein 6 h prior to the 3rd dose of ethanol. Animals were
euthanized 12 h after cell injection. In the H. felis-infected
model, a similar injection was given at 6 months of
infection. Mice were sacrificed 4 months after injection.
Histology
Mice were euthanized, the stomach removed, opened lon-
gitudinally along the greater curvature, and gently washed
with PBS (phosphate-buffered saline). Strips of gastric
tissue along the lesser curvature from the squamocolumnar
junction through the pylorus were taken, fixed in 10 %
neutral buffered formalin for 4 h, processed by standard
methods, embedded in paraffin, cut into 5-lm sections,
stained with H&E, and examined for inflammation and
architectural distortion as previously described.
Sections were scored in a blinded fashion as follows:
Inflammation 0: Normal; 1: Small multifocal leukocyte
accumulations in mucosa; 2: Coalescing mucosal inflam-
mation; early submucosal extension; 3: Coalescing mucosal
inflammation with prominent multifocal submucosal
extension ± follicle formation; 4: Severe diffuse inflam-
mation of mucosa, submucosa, with or without deeper layers.
Hyperplasia 0: Normal; 1: one and one-half times normal
thickness; 2: two times normal thickness with mitotic figures
one-third way up to surface; 3: three times normal thickness
with mitotic figures half way up to surface; 4: four times
normal thickness or greater with mitotic figures greater than
half way up to the surface. Parietal cell loss, mucous cell
hypertrophy, metaplasia and dysplasia; 0: no substantial
alterations; 1: \5 % alteration; 2: 25–50 % alteration; 3:
50–75 % alteration; 4:[75 % alteration [4].
Quantitative PCR and RT-PCR
A 2 mm 9 2 mm piece of gastric mucosa taken at the fundus/
antral border was snap-frozen at the time of necropsy. All
samples were processed using standard protocols as follows:
total mRNA (Trizol; Invitrogen, Grand Island, NY, USA);
genomic DNA (Purelink genomic DNA mini kit; Invitrogen);
reverse transcription (Omniscript RT kit; Qiagen, Valencia,
CA, USA); real-time quantitative PCR (Quantitect SYBR
green PCR kit; Qiagen) on a CFX96 Touch Real-Time PCR
detection system (Biorad, Hercules, CA, USA).
Primers: mouse SDF-1 forward: 50GAG AGC CAC
ATC GCC AGA GC and reverse: 50GGA TCC ACT TTA
ATT TCG GGT CAA. Mouse CXCR4 forward: 50GAC
CGC CTT TAC CCC GAT AGC and reverse: 50ACC CCC
AAA AGG ATG AAG GAG TC. Mouse beta actin for-
ward: 50CCT AAG GCC AAC CGT GAA AAG ATG and
reverse: 50GTC CCG GCC AGC CAG GTC CAG. RFP
forward: 50CCC GCC GAC ATC CCC GAC TAC AT and
reverse: 50CTT CAG CTT CAG GGC GTG GGA GAT.
All annealing T = 59 C.
Q-PCR experiments were run 3 times with similar results.
CXCR4 Knock-Down in Mesenchymal Stem Cells
shCXCR4-GFP constructs (clones 1, 2, 3) was purchased
from Genecopoeia (Rockville, MD, USA) and cells were
infected with clones 1, 2 and 3 in succession. The infection
efficiency was checked using GFP fluorescence.
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cAMP (Cyclic Adenosine Monophosphate) ELISA
Assay
Plates precoated with anti-cAMP antibodies (Applied
Biosystems, Bedford, MA, USA) were seeded with 50,000
cells, grown overnight, then stimulated with SDF-1 at
100 ng/ml concentration for 10 min at 37 C. Media were
aspirated and cells lysed as per manufacturer’s instructions.
The results were read by a plate luminometer at an emis-
sion of 470 nm (Perkin-Elmer, Waltham, MA, USA). The
results were plotted against the standards provided with the
kit. The experiment was run 3 times with similar results.
Transwell Cell Migration Assay
One hundred microliters of mesenchymal cells at a con-
centration of 10,000-cells/100 ll in 0.1 % fetal calf serum
were seeded in the well insert of Transwell plates with an
8-lm pore size inserts (Corning, Lowell, MA, USA). Cells
were stimulated with or without 100 ng/ml of SDF-1
overnight. Cells that migrated through the Transwell were
fixed with methanol/acetic acid (3:1 ratio), stained with
Giemsa solution (1:20 concentration) for 10 min, enu-
merated, and plotted as a ratio of its nonstimulated control
group. The experiment was run 3 times with similar results.
Western Blotting
Performed using anti-CXCR4 antibody (1/250; Abcam, UK)
and secondary antibody b-actin HRP conjugated (1/1,000;
Santa Cruz, CA, USA).
Immunohistochemistry (IHC) and Fluorescent In Situ
Hybridization (FISH)
RFP IHC using a rabbit polyclonal antibody (1/50; Rock-
land, Gilbertsville, PA, USA) [26]. FISH for Y chromo-
some on gastric tissue sections was performed as
previously described [26]. For cytokeratin detection, tissue
was then exposed to anti-pankeratin PE conjugated anti-
body (clone C11; Abcam, Cambridge, MA, USA) at a
concentration of 1/50 for 20 min at 37 C. Slides were
mounted with DAPI antifade then immediately viewed
with a fluorescent microscope (Olympus, Japan).
Statistical Analysis
Folds of relative gene expression for RFP, SDF-1, and
CXCR4 are reported as a mean ± 1SD using actin as an
internal control. Calculation of fold changes of real-time
RT-PCR was done using the 2-DDCt method; the statistical
analysis was done with the REST 2009 software (Technical
University, Munich, Germany). The remaining of statistical
analysis was done using Prism GraphPad program (La
Jolla, CA, USA). Pathology data between control group
and 2, 6, and 12 months of H. felis infection was compared
using multiple unpaired t tests of two-way ANOVA. We
applied the Bonferoni correction method where multiple
comparisons were made. Unpaired Student’s t test was
used to compare cAMP concentration in stimulated and
unstimulated cells; data are reported as a mean ± 1SD. A
value of p \ 0.05 was considered statistically significant.
Results
The Role of the CXCR4/SDF-1 Axis in H. felis-induced
Gastric Injury
First, we established the baseline of mucosal changes to H.
felis infection in our colony of mice. The normal gastric
mucosa of mice contained: chief cells, located in the lower
1/3 of the fundic mucosa; parietal cells, large eosin-positive
cells inserted between the chief cells that populate the lower
2/3 of the mucosa; and mucous cells, which are located in the
pit section of the gastric gland. Rare inflammatory cells were
seen in the submucosal layer (Fig. 1a).
At 2 months of H. felis infection, inflammation was
evident in the submucosa (Fig. 1b, arrow), along with loss
of parietal and chief cells and antralization of the glands.
At 6 months of infection, there was a complete loss of
parietal cells and the appearance of mucous metaplasia
(Fig. 1c, arrow). At 12 months of infection, small intra-
mucosal cystic glandular structures were formed (Fig. 1d,
arrow). However, these structures did not penetrate the
muscularis mucosa until 16–18 months of infection. Of the
infected mice, 75 % developed large antral masses, com-
plicated by gastric outlet obstruction at 18 months of
infection [4]. The histology scores at different time points
after H. felis infection are represented in Fig. 1e.
Both SDF-1 and CXCR4 are elevated in acute inflammation
environments and cancer. In order to test whether there is a role
of the CXCR4/SDF-1 axis in H. felis-induced gastric inflam-
mation, we evaluated the expression of SDF-1 and CXCR4 in
the gastric mucosa of infected and control mice using RT-PCR.
At 2 months of infection, there was a 30-fold increase in
expression of SDF-1, and the level remained substantially
elevated at 12 months (Fig. 1f). Over the same time course,
there was a progressive upregulation of CXCR4 in the gastric
mucosa, when compared to the control group (Fig. 1g).
CXCR4 ‘‘Loss of Function’’ Model in Culture-Adapted
MSC
Mesenchymal stem cells constitutively express intra- and
extracellular CXCR4 [28] and thus are able to respond to
Dig Dis Sci (2013) 58:2466–2477 2469
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Fig. 1 Helicobacter felis infection is associated with chronic inflam-
mation and upregulation of SDF-1 and CXCR4. Fundic mucosa taken
from the lesser curvature at the squamocolumnar junction, stained
with hematoxylin/eosin, magnification 9100. a Control noninfected
mouse; b 2 months of infection (arrow, moderate chronic submucosal
inflammatory infiltrates); c 6 months of infection, mucous cell
metaplasia and complete loss of parietal cells; d 12 months of
infection (single arrow points to dysplastic cystic noninvasive gastric
gland in the fundus; double arrows point to massive submucosal
inflammation); e histology scores from mice infected for 2, 6, and
12 months; f Gastric mucosa SDF-1 expression by RT-PCR at 2, 6,
and 12 months of infection; g gastric mucosa CXCR4 expression at 2,
6, and 12 months of infection (*p \ 0.05). Error bars mean ± 1SD
of the mean (n = 4 mice in each group)
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SDF-1 stimulation. In order to study whether CXCR4 plays
a role in MSC trafficking in H. felis-induced gastric cancer,
we took a ‘‘gene knock-down’’ approach. RFP expressing
MSC were infected in succession with three shCXCR4-
GFP constructs and the transfection efficiency of shCXCR4
and control construct (shScramble) was confirmed by GFP
expression (Fig. 2c, f). RFP expression was preserved and
did not change after shCXCR4 or shScramble transfection
(Fig. 2b, e). We confirmed the CXCR4 expression levels
with a western blot (Fig. 2g). The most effective inhibition
of CXCR4 expression was detected in the cell line trans-
fected with all three shCXCR4 constructs (Fig. 2g, lane 4).
The growth properties (doubling time) and the appearance
of shCXCR4 and shScramble cells did not change when
compared to the parental cell line (data not shown).
The function of CXCR4 in both shCXCR4 and
shScramble cells was tested using a cAMP concentration
assay and by determining cell migration capabilities
in vitro in response to SDF-1 stimulation. When stimulated
by SDF-1, CXCR4 signaling occurs by dissociation of the
Gbc subunit from the GTP bound Ga. Ga will inhibit the
adenylate cyclase function, resulting in a reduction of
cyclic AMP (cAMP) levels. shScramble cells, upon SDF-1
stimulation, decreased cAMP production (p \ 0.05) con-
firming intact signaling, while the CXCR4-deficient cells
(shCXCR4) failed to decrease the level of cAMP produc-
tion (p [ 0.05) (Fig. 2h), confirming the loss of CXCR4
expression and function.
In vitro migration was studied using a Transwell system
where shCXCR4 and shScramble cells were cultured in the
upper compartment of the insert of a plate separated from
the lower compartment by a porous 8-lm membrane.
ShScramble cells responded to SDF-1 stimulation by
almost tripling the number of cells that passed across the
membrane and attached to the plate, when compared to the
unstimulated group (Fig. 2i). On the other hand, CXCR4-
deficient cells did not respond to a SDF-1 gradient (Fig. 2j,
cells shown as attached to the bottom of the plate; Fig. 2k,
Transwell system diagram).
Acute Alcohol Injury as a Model of Acute Gastric
Inflammation in Mice
We used an acute inflammation model to test the ability of
the CXCR4-deficient cells and their controls to migrate to
the stomach. Acute ingestion of ethanol causes acute gas-
tritis in mice [27]. Five gm/kg of alcohol was given daily to
mice on four consecutive days; the mice were euthanized
on day 5. This resulted in a mucosa, which was hemor-
rhagic on gross examination and showed diffuse mucosal
ulceration and severe lymphocytic infiltration on micro-
scopic examination (Fig. 3c, control; Fig. 3d, arrow). Peak
inflammation occurred after the third dose of alcohol (72 h)
(Fig. 3b). SDF-1 was upregulated in the stomach by sixfold
after 2 doses and eightfold after 3 doses of ethanol com-
pared to the control group using RT-PCR (Fig. 3a). SDF-1
was assessed in other organs, including the colon, lung, and
spleen. The stomach was the site of maximal SDF-1
upregulation (data not shown) in response to local
inflammatory stimuli.
CXCR4 Is Required for MSC Trafficking in Alcohol-
induced Acute Gastritis Model
We hypothesize that MSC, which possess a CXCR4
receptor, will mobilize to inflammatory sites, where SDF-1
expression is abundant. In order to test this hypothesis, we
used the alcohol-induced acute gastritis model. C57BL/6
mice were given ethanol or water (control). We delivered
1 9 106 of either shScramble or shCXCR4 cells intrave-
nously 6 h prior to the 3rd dose of ethanol, when SDF-1
were at peak levels (Fig. 3a). Animals were euthanized
12 h after the cells were injected. We used PCR with RFP-
specific primers for the detection of injected MSC within
the gastric mucosa. Under baseline conditions, CXCR4-
expressing cells (shScramble) were found in the stomach at
1.9-fold of control expression. Under the alcohol-induced
gastritis conditions, the recovery of the shScramble was at
5.6-fold. We were unable to detect the presence of MSC in
mice injected with CXCR4-deficient cells (shCXCR4)
(Fig. 4a).
CXCR4 Is Partially Required for Homing of MSC
to the Stomach in H. felis-induced Gastric Cancer
Helicobacter felis-induced chronic gastric inflammation
results in upregulation of SDF-1, creating a permissive
environment for the homing of MSC potentially through a
CXCR4 mechanism. To test whether the CXCR4 receptor
is required in the homing of MSC to the stomach in the
setting of H. felis-induced chronic gastric injury, C57BL/6
mice were infected with H. felis for 6 months. At 6 months
of infection, infected and noninfected mice were injected
with 1 9 106 shCXCR4 or shScramble MSC via tail vein.
Animals of all groups were followed for another 4 months
Fig. 2 Functional knockdown of CXCR4 prevents migration of MSC
to SDF-1 in vitro. RFP-MSC transfected with GFP expressing
shScramble (a–c) and GFP-shCXCR4 constructs (d–f). Magnification
9200. g Western blot for CXCR4 and actin expression. h cAMP
concentration after a 10-min SDF-1 stimulation (dark bars) and
control (white bars). i Percentage of cells that migrate across the
Transwell barrier to a SDF-1 stimulation, shown as the percentage of
their nonstimulated group (1–100 %). j Giemsa staining of cell
migrated to SDF-1 gradient. k Cartoon depicting of experimental
design (*p \ 0.05). Error bars mean ± 1SD of the mean
c
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and then euthanized. At the time of the necropsy, all mice
appeared healthy. Upon gross examination, the stomachs of
the H. felis-infected mice that were injected with shCXCR4
and shScramble cells had an edematous and thickened
fundic mucosa. In the settings of H. felis infection, both
shScramble and shCXCR4 cells were recovered by PCR in
the stomach of mice, thus demonstrating the ability of both
cell types to home into the stomach. There was no RFP
recovered from the control, H. felis, or noninfected
shCXCR4 groups (Fig. 4c).
MSC Differentiate into Gastric Epithelial Lineages
and Have a Synergistic Effect in Promoting H. felis-
induced Gastric Cancer
Next, we determined the physiological effect of the homed
MSC on the gastric H. felis-induced carcinogenesis. We
evaluated the histology of the stomach for the presence of
inflammation, hyperplasia, and intraepithelial neoplasia. H.
felis-infected mice, with or without injected MSC, irre-
spective of the presence of CXCR4, had a higher stomach
to total body ratio when compared with the control group
(data not shown). There was no difference in the amount of
inflammation seen in the stomachs of mice from the H.
felis, H. felis ? shScramble, or H. felis ? shCXCR4
groups, nor was there any difference in the level of
hyperplasia. Of the mice from the infected and MSC-
injected groups, 75 % had developed gastric intraepithelial
A
DC
B
Fig. 3 Acute alcohol ingestion induces inflammation, tissue damage
and overexpression of local SDF-1. a SDF-1 expression in gastric
mucosa in control mice and at 48, 72, and 96 h after alcohol
ingestion. b Inflammation scores gastric mucosa at 48, 72, and 96 h
after alcohol ingestion. c, d Corresponding fundic histology at 96 h;
stained with hematoxylin/eosin, magnification 9100; arrow indicates
multiple inflammatory cells in the submucosa (*p \ 0.05). Error bars
mean ± 1SD of the mean (n = 4 mice in each group)
A
B
Fig. 4 MSC home to alcohol and H. felis-induced gastritis. Mice
were exposed to acute ethanol ingestion or chromic H. felis infection
and the migration of RFP-expressing MSC assessed by PCR. a PCR
for RFP expression in whole gastric tissue of mice exposed to alcohol.
b PCR for RFP expression in whole gastric tissue of mice exposed to
H. felis infection (*p \ 0.05). Error bars mean ± 1SD of the mean
(n = 4 mice in each group)
Dig Dis Sci (2013) 58:2466–2477 2473
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Fig. 5 MSC trafficking to the
gastric mucosa in the setting of
chronic Helicobacter-induced
inflammation results in early
gastric intraepithelial neoplasia
independent of CXCR4. a,
b Fundic mucosa taken from the
lesser curvature at the
squamocolumnar junction,
stained with hematoxylin/eosin,
magnification 9100. a Mouse
with H. felis infection and
injection with shCXCR4 cells,
Gastric Intraepithelial Neoplasia
(arrow). b Mouse with H. felis
infection and injection with
shScramble cells, Gastric
Intraepithelial Neoplasia
(arrow). c–
e Immunohistochemistry for
RFP (brown staining) on a
fundic mucosal strip,
hematoxylin counter-staining
(blue). c Control mouse,
magnification 9100. d Mouse
with H. felis infection and
injection with shScramble cells;
magnification 9100. e Mouse
with H. felis infection and
injection with shCXCR4 cells;
Dysplastic gland with RFP
positive staining (brown, arrow)
magnification 9200. f–h FISH
for Y chromosome (green
staining), DAPI stained nuclei
(blue) and anti-cytokeratin
staining (red) of mouse
stomach; magnification at
9200. f Positive control,
stomach of a male mouse. g,
h Mouse with H. felis infection
and injection with shScramble
cells; Y chromosome-positive
cells (arrows)
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neoplasia (GIN) as early as 10 months of infection. GIN
represents the presence of large dysplastic glandular
structures that penetrated into and beneath the muscularis
mucosa of the gastric mucosa (Fig. 5a, b). This phenome-
non was independent of the CXCR4 presence in the
injected MSC.
The expression of RFP was assessed using an immu-
nohistochemistry technique. RFP-positive dysplastic
glands were seen throughout the stomach of H. felis-
infected and MSC-injected mice (Fig. 5d, e, brown stain-
ing). A dysplastic RFP positive gland is shown in Fig. 4e.
The RFP staining was negative in the control group, which
did not receive a MSC injection (Fig. 5c). FISH for Y
chromosome and cytokeratin staining was used to further
delineate if the MSC differentiate into gastric epithelial
lineages. A gastric gland with cells containing Y chromo-
some staining (green, arrows), which is also positive for
cytokeratin (red), is shown in Fig. 5g, arrows. In the sub-
mucosa of the same sample, there were Y-positive, but
cytokeratin-negative cells of nonepithelial origin (Fig. 5h,
arrows).
Discussion
Mesenchymal stem cells are non-hematopoietic stromal
cells originating from bone marrow that are able to dif-
ferentiate into mesenchymal (bone, cartilage, muscle) and
non-mesenchymal (epithelial) cells [29]. Tumor microen-
vironment is a compilation of cells, which include myofi-
broblasts, inflammatory cells, inflammatory cells, and
vascular endothelial cells; all of which are considered to be
recruited from circulation or surrounding tissue with an
ability to contribute to tumor development. MSC are being
recruited at both primary tumor [30] and metastatic sites,
mostly favoring cancer progression [31]. The contribution
of MSC to the cancer development is either direct and/or
indirect, through a paracrine mechanism by secreting sol-
uble factors (cytokine, chemokines) or contribution to
angiogenesis. Cancer-associated fibroblasts (CAF), which
are known for their properties in forming the tumor
microenvironment, were shown to originate from circula-
tory MSC [9]. Thus, MSC contribute directly to the tumor
microenvironment or could serve as the resource of other
cellular components (CAF).
Homing is the initial step in which the circulating MSC
lodges within the vasculature of the injured tissue, followed
by crossing of the blood–endothelium barrier using adhe-
sion mechanisms for anchoring. The process of homing is
triggered in response to injury (acute or chronic inflam-
mation), which results in production of cytokines, chemo-
kines, and growth factors. MSC have homing capabilities
to inflamed tissues when systemically infused [32]. The
interaction of SDF-1 and CXCR4 was found to play an
important role in early trafficking and homing of MSC.
Inflammatory cytokines, TGF-b, IL-1b, and TNF-a, are
known for their ability to stimulate the production of
matrix metalloproteinases (MMP) in MSC followed by
chemotactic migration through the extracellular matrix
[33]. The process of homing of MSC at the injury site is
followed by engraftment, which is defined as a long-term
commitment of MSC to a niche where the process of
transdifferentiation into different lineages is initiated. This
process goes through the replenishing effect of the
peripheral stem cells. Engraftment is much more complex
then homing, because it requires niche-specific signaling in
order for the process of transdifferentiation to occur. In the
context of chronic inflammation-derived cancer, the pro-
cess of MSC niche transdifferentiation and self-renewal is
exposed to oxidative stress, proinflammatory cytokines,
growth factors leading to accumulation of mitotic errors
and promotion of epithelial cancers through generation of
cancer stem cells, and the components of tumor microen-
vironment, myofibroblasts, and endothelial cells.
In this study, we analyzed the mechanisms of mesen-
chymal stem cells trafficking into the chronic inflamed
gastric mucosa in the setting of Helicobacter infection. Our
initial results showed that both CXCR4 and SDF-1 are
indeed upregulated in the gastric mucosa of mice infected
with H. felis, thus demonstrating that the Helicobacter-
induced gastric cancer model is indeed a favorable chronic
injury environment for MSC homing and engraftment. A
similar pattern of changes was revealed in human gastric
cancer [20]. In order to study whether the CXCR4/SDF-1
axis plays a role in MSC trafficking to the gastric inflamed
mucosa, we used a CXCR4 gene knock-down approach.
First, we looked to establish an acute injury model for MSC
homing in the gastric mucosa using an acute alcohol-
induced gastritis model. We determined that CXCR4 was
required for homing of MSC to the gastric mucosa as
CXCR4-deficient cells were not detectible in the acutely
injured mucosa.
Next, we tested whether CXCR4 is required for
engraftment of MSC into the gastric mucosa in the settings
of H. felis-induced gastric cancer. Our results showed that,
irrespective of the presence of CXCR4, MSC contributed
to the development of a more advanced form of gastric
cancer, as 75 % of mice injected with MSC acquired GIN.
This also suggested that, while acute inflammation and
homing appear to be CXCR4/SDF-1-dependent, chronic
inflammation and recruitment of MSC relies on alternate
molecular pathways. Our findings could be explained by
the fact that other chemokine receptors, for example
CXCR7, might be employed by MSC to home and/or
engraft into gastric mucosa in the setting of chronic H.
felis-induced inflammation, while in the acute
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inflammation (alcohol) setting, the CXCR4/SDF-1 axis is
sufficient to promote homing of MSC.
Mice receiving MSC in the setting of H. pylori infection
had a more advanced form of gastric neoplasia, supporting
the notion that MSC could be considered as a possible
source of tumor initiating cells in the hierarchical model of
gastric cancer. We performed immunohistochemistry
(Fig. 4d, e) and FISH (Fig. 5g, h) analysis to track the
MSC and their engraftment in the gastric mucosa. Injected
MSC were detected in the dysplastic gastric glands (RFP-
positive cells), which was further supported by the co-
staining for Y chromosome and cytokeratin. Cytokeratin-
negative and chromosome Y-positive cells detected in the
submucosa may also suggest a possible contribution of
MSC to the tumor-supporting cells. Understanding the
molecular mechanisms of how MSC home and engraft into
the chronic gastric inflammation sites, thus promoting a
more advanced form of gastric cancer, is important, as it
may provide clues in how to target the pathway of patho-
genesis (i.e. the CXCR4/SDF-1 axis) of stomach cancer.
In conclusion, the presence of chronic inflammation
recruits and retains circulating MSC, and the retention of
transformed MSC accelerates GIN. The homing of MSC
acutely to the stomach is dependent on CXCR4; however,
the chronic engraftment of MSC is independent of CXCR4
in the setting of Helicobacter-induced gastric cancer.
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